Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Gyrodyne, LLC | Former 10% Owner | Common Stock | 144K | $1.87M | $13.00 | Aug 30, 2021 | Direct |
NovaBay Pharmaceuticals, Inc. | 10%+ Owner | Common Stock, par value $0.01 per share | 1.02M | $474K | $0.47 | Apr 8, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NBY | NovaBay Pharmaceuticals, Inc. | Apr 2, 2025 | 4 | $16K | 4 | Apr 15, 2025 | 10%+ Owner |
NBY | NovaBay Pharmaceuticals, Inc. | Mar 26, 2025 | 6 | $74.5K | 4 | Apr 15, 2025 | 10%+ Owner |
NBY | NovaBay Pharmaceuticals, Inc. | Mar 18, 2025 | 6 | $30.7K | 4 | Apr 15, 2025 | 10%+ Owner |
NBY | NovaBay Pharmaceuticals, Inc. | Mar 10, 2025 | 6 | $39.5K | 4 | Apr 15, 2025 | 10%+ Owner |
NBY | NovaBay Pharmaceuticals, Inc. | Feb 25, 2025 | 6 | $29.9K | 4 | Apr 15, 2025 | 10%+ Owner |
NBY | NovaBay Pharmaceuticals, Inc. | Feb 3, 2025 | 6 | $55.5K | 4 | Apr 15, 2025 | 10%+ Owner |
NBY | NovaBay Pharmaceuticals, Inc. | Jan 27, 2025 | 2 | $67.7K | 4 | Apr 15, 2025 | 10%+ Owner |
NBY | NovaBay Pharmaceuticals, Inc. | Jan 10, 2025 | 0 | $0 | 3 | Apr 7, 2025 | 10%+ Owner |
GYRO | Gyrodyne, LLC | Aug 27, 2021 | 2 | -$472K | 4/A | Aug 30, 2021 | Former 10% Owner |